Search results for "ALAT"

High-nuclearity Ni-substituted polyoxometalates: a series of poly(polyoxotungstate)s containing 20–22 nickel centers.

2011

Three high-nuclearity Ni-substituted polyoxotungstates (POTs)--[Ni(enMe)2(H2O)2]2[Ni(H2O)6]2[Ni(enMe)2][Ni(H2O)2]1.5[HNi20X4W34(OH)4O136(H2O)6(enMe)8]·11 H2O (3), [Ni(en)2(H2O)]2[H8Ni21X4W34(OH)4O136(en)10(H2O)5]·22 H2O (4), and [Ni(enMe)2]2[H6Ni22X4W34(OH)4O136(H2O)6(enMe)10]·18 H2O (5), in which en = ethylenediamine, enMe = 1,2-diaminopropane, X = 0.5 P+0.5 Ge--were made under hydrothermal conditions and characterized by IR spectroscopy, elemental analysis, thermogravimetric analysis, powder X-ray diffraction, and single-crystal X-ray diffraction. The structures of 3–5 can be viewed as novel derivatives of [H6Ni20P4W34(OH)4O136(enMe)8(H2O)6]·12 H 2O (1) and [Ni(en)2(H2O)]2[H8Ni20P4W34(OH)…

Structural Characterisation of Complex Layered Double Hydroxides and TGA-GC-MS Study on Thermal Response and Carbonate Contamination in Nitrate- and …

2015

Layered double hydroxides (LDHs) are versatile materials used for intercalating bioactive molecules in the fields of pharmaceuticals, nutraceuticals and cosmetics, with the purpose of protecting them from degradation, enhancing their water solubility to increase bioavailability and improving their pharmacokinetic properties and formulation stability. Moreover, LDHs are used in various technological applications to improve stability and processability. The crystal chemistry of hydrotalcite-like compounds was investigated by X-ray powder diffraction (XRPD), automated electron diffraction tomography (ADT) and thermogravimetric analysis (TGA)-GC-MS to shed light on the mechanisms involved in io…

Paroxysmal nocturnal hemoglobinuria-like phenotype and thrombotic risk in several clinical disorders.

2021

The Essential Thrombocythemia, Thrombotic Risk Stratification, and Cardiovascular Risk Factors

2020

Essential thrombocythemia is a rare hematological malignancy with good overall survival, but moderate to high risk of developing arterial or venous thrombosis lifelong. Different thrombotic risk scores for patients with essential thrombocythemia have been proposed, but only one of them (the IPSET-t scoring system) takes into account the classical cardiovascular risk factors as one of the scoring items. Currently, in clinical practice, the presence of cardiovascular risk factors in patients with diagnosis of ET rarely determines the decision to initiate cytoreductive therapies. In our study, we compared different risk models to estimate the thrombotic risk of 233 ET patients and the role of …

TiO2 Impregnato con Poliossometallato Utilizzato come Fotocatalizzatore nella Degradazione di 2-Propanolo in Fase Vapore

2008

Tick Bites - the View from Inside-Out

2009

The tick feeding process in humans and its effects on the host skin have been studied histologically on specimens of tick bites, some of which included the attached parasite, and on ticks extracted from lesions or caught in the wild. The specimens, included in paraffin, were stained with hematoxylin-eosin, orcein–Giemsa for elastic fibers, periodic acid-Schiff for polysaccharides, Weigert method for fibrin, Warthin-Starry stain for spirochetes, and Bodian’s method for nerve fibers. The mouthparts of the attached ticks were embedded in a cement cone, with the chelicerae and the hypostome lining the oral canal, while the basis capituli contained the pharynx with its anti-reflux valves, the hy…

Prolonged anaesthesia with isoflurane and halothane. Effects on hepatic function.

2007

Hepatic function was assessed pre-operatively and on the first and sixth postoperative days in 40 healthy patients who underwent prolonged maxillofacial surgery with isoflurane or halothane anaesthesia. No major changes were observed in hepatic enzymes or bilirubin. One-stage prothrombin time and Factor VII concentrations decreased on the first postoperative day and this change was more pronounced in the halothane group. The results support the use of isoflurane rather than halothane for prolonged anaesthesia in respect of the synthesising function of the liver.

Secretion of neutral and acid DNases in cultivated human lymphocytes after incubation with DNA; possible consequences for inhalation anesthesia.

1995

Abstract After incubation with DNA human lymphocytes release neutral and acid DNase activities into the culture medium; the release depends on DNA concentration and time of cultivation. The electrophoretic mobility of the released neutral DNase activity is in accordance with DNase I and the electrophoretic mobility of the released acid DNase activity with DNase II. The released DNase activities do not originate from dead cells and are not influenced by blast cell formation. The anesthetic halothane can inhibit the released neutral and acid DNase activities. Inhalation anesthesia can possibly disturb the correlation between DNA and DNases in human blood.

The effect of ions at the surface of calcium oxalate monohydrate crystals on cell-crystal interactions

2003

Magnesium is an abundant ion in biologic systems, including renal tubular fluid; however, the precise role of magnesium during the interaction of calcium oxalate crystals with cells has not been previously defined. In addition, the respective roles of calcium and hydrogen ions during the cell-crystal bonding interaction remain poorly defined. Here we report an atomic level three-dimensional study of a single crystal of calcium oxalate monohydrate (COM; whewellite) which was bathed in a solution of magnesium hexahydrate for 1 year. Magnesium was not incorporated into the structure of whewellite to any significant degree. Instead, COM accepted magnesium primarily as an adsorbate in a binding …

Profile of glycopyrronium for once-daily treatment of moderate-to-severe COPD

2012

Bronchodilators are central in the symptomatic management of chronic obstructive pulmonary disease (COPD). Long-acting muscarinic antagonists (LAMAs) and long-acting β(2)-agonists (LABAs) are the main classes of long-acting bronchodilators. To date, tiotropium is the only once-daily LAMA available for the treatment of COPD. Glycopyrronium is a novel LAMA, currently in development for COPD. Phase II studies have shown that glycopyrronium 50 μg once daily provides clinically significant 24-hour bronchodilation with a rapid onset of action, which is faster than that of tiotropium, and a favorable safety and tolerability profile. The Phase III GLycopyrronium bromide in COPD airWays (GLOW) progr…